miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2)

Published:2018-09-18 Issue:1 Volume:37 Page:
ISSN:1756-9966
Container-title:Journal of Experimental & Clinical Cancer Research
language:en
Short-container-title:J Exp Clin Cancer Res

Author:

He Xi,Chen Si-yuan,Yang Zhao,Zhang Jie,Wang Wei,Liu Mei-yue,Niu Yi,Wei Xiao-mei,Li Hong-min,Hu Wan-ning,Sun Guo-gui

Funder

the National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13046-018-0882-4.pdf

Reference55 articles.

1. Behm-Ansmant I, Rehwinkel J, Izaurralde E. MicroRNAs silence gene expression by repressing protein expression and/or by promoting mRNA decay. Cold Spring Harb Symp Quant Biol. 2006;71:523–30.

2. Krichevsky AM, King KS, Donahue CP, Khrapko K, Kosik KSA. microRNA array reveals extensive regulation of microRNAs during brain development. RNA. 2003;9(10):1274–81.

3. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–97.

4. Yu SL, Chen HY, Chang GC, Chen CY, Chen HW, Singh S, et al. MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell. 2008;13(1):48–57.

5. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell. 2006;9(3):189–98.

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ZEB1‐AS1 mediates bone metastasis through targeting miR‐320b/BMPR1A axis in lung cancer;The Clinical Respiratory Journal;2024-05

2. CCND2 is a prognostic biomarker and correlates with immune infiltration in lung adenocarcinoma;Translational Cancer Research;2024-03

3. Regulation and therapeutic potentials of microRNAs to non-small cell lung cancer;Heliyon;2023-11

4. Non-Small Cell Lung Cancer Brain Metastasis: The Link between Molecular Mechanisms and Novel Therapeutic Approaches;Cancer Metastasis - Molecular Mechanism and Clinical Therapy;2023-03-08

5. Identification and validation of hub genes in CD5-positive diffuse large B-cell lymphoma;Experimental Biology and Medicine;2023-02-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3